Skip to content

Patient-Centered Reproductive Decision Support Tool for Women Veterans

MyPath: A Patient-Centered Web-Based Intervention to Improve Reproductive Planning for Women Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04584294
Acronym
MyPath
Enrollment
465
Registered
2020-10-12
Start date
2021-03-01
Completion date
2025-09-30
Last updated
2025-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Contraception Behavior, Prepregnancy Health, Reproductive Health

Keywords

Shared decision making, Primary care, Patient decision support, Patient-centered outcomes research, Reproductive autonomy, Patient-Centered Care, Provider-Patient Communication

Brief summary

The investigators have developed a web-based decision support tool to help women Veterans get the information and care they need to achieve their reproductive goals, whether that includes optimizing their health before desired pregnancies or birth control to avoid unwanted pregnancies. The study will test the effect of sending a weblink to the decision tool to women Veterans prior to primary care visits at the VA. Half of participants will be sent a weblink before their appointment, and half will not be sent the link. The investigators hypothesize that participants who are sent the link will be more likely to report patient-centered discussions of their reproductive needs at visits, feel confident in communicating with their health care providers, have accurate knowledge about reproductive health, and choose birth control methods that best fit their preferences and needs.

Detailed description

Counseling and care that supports individuals' ability to achieve their reproductive goals is an essential component of primary care. National organizations, including the Centers for Disease Control and Prevention (CDC), recommend that clinicians routinely engage in patient-centered conversations about reproductive goals and offer care to help optimize health and well-being prior to desired pregnancies and to prevent unwanted pregnancy and births. This counseling is particularly critical for women Veterans, who face elevated risks of adverse pregnancy and birth outcomes due to a high prevalence of chronic medical and mental health conditions as well as psychosocial stressors including sexual trauma histories, intimate partner violence, and homelessness. Moreover, stark racial/ethnic disparities in pregnancy outcomes are well-documented, and nearly half of reproductive-aged women Veterans are minority race/ethnicity. Despite these national recommendations, however, conversations about reproductive needs are often absent in primary care both outside and within the VA, and the conversations that do happen frequently fail to incorporate women's values and preferences. Interventions are needed to improve both the frequency and quality of counseling about reproductive needs in primary care settings. This study will investigate the effect of a novel, web-based, patient-facing decision support tool designed to be used prior to VA primary care visits to help women Veterans with reproductive capacity consider their reproductive goals; improve their knowledge about fertility, contraception, and prepregnancy health risks; align contraceptive decisions with their preferences and goals; and engage in shared decision making (SDM) with providers. The investigators will conduct a multi-site randomized controlled trial (RCT) clustered at the provider level among VA primary care providers and their reproductive-aged women Veteran patients. Study outcomes will be assessed among participants shortly after their scheduled appointment and at 3- and 6-months follow up. The study will test the primary hypothesis that participants who receive the tool weblink prior to visits will be more likely to report patient-centered conversations about their reproductive needs at their visit. The investigators also hypothesize that intervention participants will report higher perceived self-efficacy in communicating with providers, reproductive health knowledge, contraception decision quality, and contraception utilization. Exploratory outcomes include behaviors to modify preconception health risks among participants considering pregnancy in the future and intervention effects by race/ethnicity. The study will also collect quantitative and qualitative data to assess the feasibility of implementing the tool more widely in VA primary care settings.

Interventions

BEHAVIORALMyPath Web-Based Informational and Decision Support Tool

The MyPath Decision Support Tool includes the following sections and features: * Questions to capture reproductive goals and orientations towards a potential pregnancy * Education modules about the menstrual cycle, fertility, and prepregnancy health with the opportunity to flag topics that are relevant and of interest to the patient * A contraceptive decision module that provides education, elicits patient preferences about different aspects of contraception, and suggests methods most appropriate based on the patient's preferences * A feature for adding free-text questions that patients may have for their provider * An email with a summary page that the patient can bring to a visit to guide discussions with primary care providers about reproductive needs

Sponsors

Kaiser Permanente
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

Research assistants (RAs) who assess outcomes will remain blinded to provider study arm assignment throughout the trial. RAs will be blinded to patient study arm assignment during patient enrollment and baseline surveys but will become unblinded to individual patient study arm assignment during the course of outcome assessment.

Intervention model description

Provider participants are randomized to one of two groups - usual care or intervention group - at the start of the study, prior to any Veteran enrollment. Subsequently, Veterans scheduled to see these providers will be enrolled as patient participants and automatically allocated to the study group of their scheduled provider.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

Patients: * Female sex identified in medical record * 18 - 44 years old * Has a scheduled VA medical appointment with an enrolled study provider * Has at least one valid telephone number available in medical record * Interested in receiving information or talking with their provider about pregnancy and/or birth control Providers: * Primary Care Provider (MD, Nurse Practitioner, Physician Assistant) at a study site * Designated as a Women's Health Provider \[defined in VA directive 1330.01 as primary care providers who have demonstrated proficiency (e.g. pelvic exams and pap smears) in women's health and who have at least 10% of their panel comprised of women\] * Completed appointments with at least 30 unique female patients ages 18-44 in the past year at a study site

Exclusion criteria

Patients: * Currently pregnant * Medical record or self-reported history of hysterectomy, bilateral oophorectomy; or self-report of not having a uterus * Unable to communicate in English * Impaired decision-making * Used the decision tool prior to study enrollment (e.g. during pilot testing of the tool) Providers: * Previous involvement as a provider in MyPath pilot work (identified by the PI) * Medical trainee * Self-report that they have plans to leave VA, go on extended leave, retire, stop primary care practice, or change VA site in the 18 months following their enrollment

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Within one month post-visitSelf-report of whether a discussion occurred during the scheduled primary care visit about pregnancy goals, prepregnancy health, or contraception that included shared decision making (SDM). SDM is measured by participant self-report with the CollaboRATE scale, which uses three 5-point Likert scale questions to assess SDM (score 0-12, with higher scores indicating more shared decision making; SDM defined using a top box score).

Secondary

MeasureTime frameDescription
Occurrence of Reproductive Needs DiscussionWithin one month post-visitSelf-report of whether a discussion of pregnancy goals, prepregnancy health, or contraception occurred during the scheduled primary care visit, regardless of occurrence of SDM.
Perceived Self-efficacy in Communicating With ProvidersWithin one month post-visitAssessed with a modified version of the validated 5-item Perceived Efficacy in Patient-Provider Interactions (PEPPI) scale, which uses five Likert scale questions ranging from 1 to 5 (score 5-25, with higher scores indicating higher levels of perceived efficacy).
Reproductive Health KnowledgeWithin one month post-visitParticipant responses to 14 items assessing knowledge of fertility, prepregnancy health, and contraception. The measure is self-developed and derived from previously published assessments of fertility and contraceptive knowledge. Responses will be coded as correct vs. incorrect, with don't know coded as incorrect (score 0-14, with higher scores indicating more accurate knowledge).
Contraceptive Decision ConflictWithin one month post-visitAssessed with the Decision Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16-items with 5-point Likert scale response options ranging from 0-4. Scores are converted to range from 0 (no decisional conflict) to 100 (highest decisional conflict). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Confidence That Contraceptive Method is Right for me.Within one month post-visitAssessed using a single question (How confident are you that this contraceptive method is right for you?) with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Choice of Prescription or Procedural Contraceptive MethodWithin one month post-visitSelf-report of continuing or changing to a prescription or procedural method after their visit. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Choice of Procedural Contraceptive MethodWithin one month post-visitSelf-report of continuing or changing to a procedural method after their visit. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Use of Prescription or Procedural Contraceptive Method6 monthsSelf-reported use of a prescription or procedural method at follow-up. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Incidence of Unplanned Pregnancy6 monthsProportion of participants who self-report an unplanned pregnancy, as determined by responses to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items measuring attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Confidence That Current Contraceptive Method is Right for me.6 monthsAssessed using a single question (How confident are you that this contraceptive method is right for you?) with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Use of Procedural Contraceptive Method6 monthsSelf-reported use of a procedural method at follow-up. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Continuous Use of Any Contraception6 monthsSelf-reported use of a contraceptive method over the past 6 months without a gap of greater than 4 weeks. This combines self-reported use at 3 months and 6 months. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For participants lost to follow-up at the 6 month timepoint, their 6-month values will be singly imputed, carrying forward 3-month continuous use reports when those data are available.
Continuous Use of Prescription or Procedural Contraception6 monthsSelf-reported use of a prescription or procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Continuous Use of Procedural Contraception6 monthsSelf-reported use of a procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.
Contraceptive Method Satisfaction6 monthsAssessed using a single question (How satisfied are you with your current birth control method) with Likert response options from 1 (very dissatisfied) to 5 (very satisfied). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. While this outcome was measured at 6 months, for participants lost to follow-up at 6 months, we singly imputed these data by pulling forward their 3-month satisfaction, when available.

Other

MeasureTime frameDescription
Goals-concordant Contraceptive Use6 monthsSelf-reported contraception use among participants at 6 months that is consistent with their orientation towards pregnancy at 6-months (desires pregnancy now, not trying but OK with it, desires pregnancy later but not now, never desires pregnancy, not sure), regardless of their intention at baseline. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For Veterans who desire pregnancy now, goals-concordant contraceptive use is defined as not using contraception. For Veterans who desire pregnancy later, never, or are unsure, goals-concordant contraceptive use is defined as using contraception. For Veterans who are not trying to get pregnant but would be OK with it, goals-concordant contraceptive use is defined as either using or not using contraception.
Contraceptive KnowledgeWithin one month post-visitParticipant responses to 8 items assessing knowledge of contraception. The measure derived from previously published assessments of contraceptive knowledge. Responses will be coded as correct vs. incorrect, with don't know coded as incorrect (score 0-8, with higher scores indicating more accurate knowledge).

Countries

United States

Participant flow

Recruitment details

VA primary care providers from 12 VA healthcare systems were enrolled and randomized to the intervention or control arm of the study. Veteran patients were subsequently recruited and enrolled into the study if they had an upcoming, scheduled appointment with a study provider. Veterans were automatically assigned to the study arm of the provider they were scheduled to see.

Participants by arm

ArmCount
Intervention (MyPath) Patients
Patients scheduled to see providers randomized to this arm received a weblink to the MyPath decision tool via text message after study enrollment and prior to their scheduled visit.
190
Usual Care Patients
Patients scheduled to see providers randomized to the usual care arm received no intervention text message and received usual care.
159
Intervention (MyPath) Providers
This arm includes providers who were randomized to the intervention arm of the study and had at least one patient subsequently enroll.
34
Usual Care Providers
This arm includes providers who were randomized to the usual care arm of the study and had at least one patient subsequently enroll.
32
Total415

Withdrawals & dropouts

PeriodReasonFG000FG001
3-month Follow-up - PATIENTSWithdrawal by Subject21
6-month Follow-up - PATIENTSWithdrawal by Subject42
Enrollment to Post-Visit - PATIENTSDid not attend scheduled appointment with primary care provider1618
Enrollment to Post-Visit - PATIENTSPregnancy01
Enrollment to Post-Visit - PATIENTSWithdrawal by Subject34
Enrollment to Post-Visit - PROVIDERSNo Veterans Enrolled in Study35

Baseline characteristics

CharacteristicIntervention (MyPath) PatientsUsual Care PatientsIntervention (MyPath) ProvidersUsual Care ProvidersTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants2 Participants0 Participants2 Participants
Age, Categorical
Between 18 and 65 years
190 Participants159 Participants32 Participants32 Participants413 Participants
Age, Continuous35.5 years of age35.1 years of age47.7 years of age47.7 years of age37.3 years of age
Annual household income
<$20,000
9 Participants9 Participants0 Participants0 Participants18 Participants
Annual household income
$20,000-$79,999
104 Participants93 Participants0 Participants0 Participants197 Participants
Annual household income
>=$80,000
67 Participants52 Participants0 Participants0 Participants119 Participants
Annual household income
Missing
10 Participants5 Participants34 Participants32 Participants81 Participants
Appointment modality
Does not apply (for providers)
0 Participants0 Participants34 Participants32 Participants66 Participants
Appointment modality
In-person appointment
156 Participants122 Participants0 Participants0 Participants278 Participants
Appointment modality
Virtual/telephone appointment
34 Participants37 Participants0 Participants0 Participants71 Participants
Current thoughts/desires regarding pregnancy
Desires pregnancy now
21 Participants19 Participants0 Participants0 Participants40 Participants
Current thoughts/desires regarding pregnancy
Does not desire a future pregnancy (ever)
60 Participants45 Participants0 Participants0 Participants105 Participants
Current thoughts/desires regarding pregnancy
Missing or Unknown
0 Participants0 Participants34 Participants32 Participants66 Participants
Current thoughts/desires regarding pregnancy
Not now, but desires pregnancy in future
55 Participants46 Participants0 Participants0 Participants101 Participants
Current thoughts/desires regarding pregnancy
Not trying to get pregnant, but okay with it
23 Participants27 Participants0 Participants0 Participants50 Participants
Current thoughts/desires regarding pregnancy
Unsure about pregnancy desires
31 Participants22 Participants0 Participants0 Participants53 Participants
Education
Bachelor's Degree or Higher
91 Participants87 Participants0 Participants0 Participants178 Participants
Education
Missing or Unknown
1 Participants0 Participants34 Participants32 Participants67 Participants
Education
Some college or Associate's Degree
81 Participants61 Participants0 Participants0 Participants142 Participants
Education
Some high school or GED
17 Participants11 Participants0 Participants0 Participants28 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
40 Participants31 Participants4 Participants2 Participants77 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
150 Participants128 Participants30 Participants30 Participants338 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Ever experienced racial discrimination in VA care
Missing
3 Participants2 Participants34 Participants32 Participants71 Participants
Ever experienced racial discrimination in VA care
No
150 Participants137 Participants0 Participants0 Participants287 Participants
Ever experienced racial discrimination in VA care
Yes
37 Participants20 Participants0 Participants0 Participants57 Participants
Has >=1 chronic medical condition (self-report)
>=1 chronic medical condition
131 Participants110 Participants0 Participants0 Participants241 Participants
Has >=1 chronic medical condition (self-report)
Missing
0 Participants0 Participants34 Participants32 Participants66 Participants
Has >=1 chronic medical condition (self-report)
No chronic medical condition
59 Participants49 Participants0 Participants0 Participants108 Participants
Has >=1 mental health condition (self-report)
>=1 mental health condition
158 Participants140 Participants0 Participants0 Participants298 Participants
Has >=1 mental health condition (self-report)
Missing
0 Participants0 Participants34 Participants32 Participants66 Participants
Has >=1 mental health condition (self-report)
No mental health condition
32 Participants19 Participants0 Participants0 Participants51 Participants
Health Insurance Status
Missing or Unknown
1 Participants0 Participants34 Participants32 Participants67 Participants
Health Insurance Status
No (VA coverage only)
94 Participants94 Participants0 Participants0 Participants188 Participants
Health Insurance Status
Yes (separate health insurance)
95 Participants65 Participants0 Participants0 Participants160 Participants
History of military deployment
Missing
1 Participants0 Participants34 Participants32 Participants67 Participants
History of military deployment
No (never deployed)
81 Participants79 Participants0 Participants0 Participants160 Participants
History of military deployment
Yes (deployed)
108 Participants80 Participants0 Participants0 Participants188 Participants
History of military sexual trauma (MST)
Does not apply (providers)
0 Participants0 Participants34 Participants32 Participants66 Participants
History of military sexual trauma (MST)
No
112 Participants88 Participants0 Participants0 Participants200 Participants
History of military sexual trauma (MST)
Yes
78 Participants71 Participants0 Participants0 Participants149 Participants
History of prior appointment(s) with study provider
Does not apply (providers)
0 Participants0 Participants34 Participants32 Participants66 Participants
History of prior appointment(s) with study provider
No (no prior appointment(s) documented)
55 Participants23 Participants0 Participants0 Participants78 Participants
History of prior appointment(s) with study provider
Yes (prior appointment(s) documented)
135 Participants136 Participants0 Participants0 Participants271 Participants
Participants enrolled by study provider practice setting
Non-women's clinic provider
117 Participants103 Participants25 Participants24 Participants269 Participants
Participants enrolled by study provider practice setting
Women's clinic provider
73 Participants56 Participants9 Participants8 Participants146 Participants
Participants enrolled per study provider5.6 Veteran participants per provider5.0 Veteran participants per provider5.6 Veteran participants per provider5.0 Veteran participants per provider5.3 Veteran participants per provider
Provider Type
Does not apply (patients)
190 Participants159 Participants0 Participants0 Participants349 Participants
Provider Type
Nurse Practitioner
0 Participants0 Participants11 Participants5 Participants16 Participants
Provider Type
Physician
0 Participants0 Participants21 Participants24 Participants45 Participants
Provider Type
Physician Assistant
0 Participants0 Participants2 Participants3 Participants5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
8 Participants0 Participants0 Participants0 Participants8 Participants
Race (NIH/OMB)
Asian
3 Participants8 Participants7 Participants11 Participants29 Participants
Race (NIH/OMB)
Black or African American
84 Participants57 Participants6 Participants5 Participants152 Participants
Race (NIH/OMB)
More than one race
12 Participants7 Participants1 Participants0 Participants20 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants0 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
15 Participants13 Participants3 Participants3 Participants34 Participants
Race (NIH/OMB)
White
67 Participants73 Participants17 Participants13 Participants170 Participants
Satisfaction with VA care, past 12 months
Missing
5 Participants1 Participants34 Participants32 Participants72 Participants
Satisfaction with VA care, past 12 months
No
69 Participants54 Participants0 Participants0 Participants123 Participants
Satisfaction with VA care, past 12 months
Yes
116 Participants104 Participants0 Participants0 Participants220 Participants
Sex: Female, Male
Female
190 Participants159 Participants32 Participants29 Participants410 Participants
Sex: Female, Male
Male
0 Participants0 Participants2 Participants3 Participants5 Participants
Sexual Orientation
Bisexual/Pansexual
22 Participants19 Participants0 Participants0 Participants41 Participants
Sexual Orientation
Lesbian/Gay
14 Participants14 Participants0 Participants0 Participants28 Participants
Sexual Orientation
Missing or Unknown
0 Participants0 Participants34 Participants32 Participants66 Participants
Sexual Orientation
Other
5 Participants6 Participants0 Participants0 Participants11 Participants
Sexual Orientation
Straight/Heterosexual
149 Participants120 Participants0 Participants0 Participants269 Participants
Sex with a male partner, past 12 months
Missing or Unknown
0 Participants1 Participants34 Participants32 Participants67 Participants
Sex with a male partner, past 12 months
No
43 Participants41 Participants0 Participants0 Participants84 Participants
Sex with a male partner, past 12 months
Yes
147 Participants117 Participants0 Participants0 Participants264 Participants
Years practicing in VA
>=10 years
0 Participants0 Participants11 Participants12 Participants23 Participants
Years practicing in VA
5-10 years
0 Participants0 Participants10 Participants11 Participants21 Participants
Years practicing in VA
<5 years
0 Participants0 Participants13 Participants8 Participants21 Participants
Years practicing in VA
Missing
190 Participants159 Participants0 Participants1 Participants350 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 2090 / 1820 / 370 / 37
other
Total, other adverse events
0 / 2090 / 1820 / 370 / 37
serious
Total, serious adverse events
0 / 2090 / 1820 / 370 / 37

Outcome results

Primary

Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)

Self-report of whether a discussion occurred during the scheduled primary care visit about pregnancy goals, prepregnancy health, or contraception that included shared decision making (SDM). SDM is measured by participant self-report with the CollaboRATE scale, which uses three 5-point Likert scale questions to assess SDM (score 0-12, with higher scores indicating more shared decision making; SDM defined using a top box score).

Time frame: Within one month post-visit

Population: Enrolled Veterans were excluded from the analytic sample if they were withdrawn from the study prior to any outcomes assessment due to non-attendance at their scheduled primary care visit, pregnancy diagnosed at the scheduled primary care visit, or self-withdrawal prior to outcomes assessment.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Yes (discussion with SDM occurred)29 Participants
Intervention (MyPath)Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)No (discussion with SDM did not occur)139 Participants
Intervention (MyPath)Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Missing (lost to follow-up for the post-visit survey)21 Participants
Intervention (MyPath)Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Missing (declined to answer one or more outcome measure questions)1 Participants
Usual CareOccurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Missing (declined to answer one or more outcome measure questions)3 Participants
Usual CareOccurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Yes (discussion with SDM occurred)20 Participants
Usual CareOccurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)Missing (lost to follow-up for the post-visit survey)17 Participants
Usual CareOccurrence of Reproductive Needs Discussion With Shared Decision Making (SDM)No (discussion with SDM did not occur)119 Participants
Comparison: We used a multilevel logistic regression model to test whether the outcome was significantly different in the intervention versus control arm. Analyses accounted for missing data in outcome and a priori adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE).p-value: 0.3195% CI: [0.7, 3.06]Regression, Logistic
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome. Our model accounted for missing data in outcome and baseline adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE) in R.Regression, Logistic
Secondary

Choice of Prescription or Procedural Contraceptive Method

Self-report of continuing or changing to a prescription or procedural method after their visit. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Choice of Prescription or Procedural Contraceptive MethodPrescription or procedural method52 Participants
Intervention (MyPath)Choice of Prescription or Procedural Contraceptive MethodNon-prescription or no method25 Participants
Intervention (MyPath)Choice of Prescription or Procedural Contraceptive MethodMissing (lost to follow-up)7 Participants
Intervention (MyPath)Choice of Prescription or Procedural Contraceptive MethodMissing (did not answer question(s))2 Participants
Usual CareChoice of Prescription or Procedural Contraceptive MethodMissing (did not answer question(s))2 Participants
Usual CareChoice of Prescription or Procedural Contraceptive MethodPrescription or procedural method35 Participants
Usual CareChoice of Prescription or Procedural Contraceptive MethodMissing (lost to follow-up)10 Participants
Usual CareChoice of Prescription or Procedural Contraceptive MethodNon-prescription or no method17 Participants
Secondary

Choice of Procedural Contraceptive Method

Self-report of continuing or changing to a procedural method after their visit. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Choice of Procedural Contraceptive MethodProcedural method28 Participants
Intervention (MyPath)Choice of Procedural Contraceptive MethodMissing (lost to follow-up for post-visit survey)7 Participants
Intervention (MyPath)Choice of Procedural Contraceptive MethodNon-procedural or no method49 Participants
Intervention (MyPath)Choice of Procedural Contraceptive MethodMissing (did not answer question(s))2 Participants
Usual CareChoice of Procedural Contraceptive MethodNon-procedural or no method32 Participants
Usual CareChoice of Procedural Contraceptive MethodProcedural method20 Participants
Usual CareChoice of Procedural Contraceptive MethodMissing (did not answer question(s))2 Participants
Usual CareChoice of Procedural Contraceptive MethodMissing (lost to follow-up for post-visit survey)10 Participants
Secondary

Confidence That Contraceptive Method is Right for me.

Assessed using a single question (How confident are you that this contraceptive method is right for you?) with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Confidence That Contraceptive Method is Right for me.4.29 Scores on a scaleStandard Deviation 1.05
Usual CareConfidence That Contraceptive Method is Right for me.4.29 Scores on a scaleStandard Deviation 1.06
Comparison: We used a multilevel regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach.p-value: 0.8495% CI: [-0.38, 0.47]Regression, Linear
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome.p-value: 0.2795% CI: [-0.35, 1.25]Regression, Linear
Secondary

Confidence That Current Contraceptive Method is Right for me.

Assessed using a single question (How confident are you that this contraceptive method is right for you?) with Likert response options from 1 (not at all confident) to 5 (completely confident). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Confidence That Current Contraceptive Method is Right for me.4.26 Scores on a scaleStandard Deviation 0.9
Usual CareConfidence That Current Contraceptive Method is Right for me.4.21 Scores on a scaleStandard Deviation 0.98
Secondary

Continuous Use of Any Contraception

Self-reported use of a contraceptive method over the past 6 months without a gap of greater than 4 weeks. This combines self-reported use at 3 months and 6 months. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For participants lost to follow-up at the 6 month timepoint, their 6-month values will be singly imputed, carrying forward 3-month continuous use reports when those data are available.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Continuous Use of Any ContraceptionContinuous use over 6 months62 Participants
Intervention (MyPath)Continuous Use of Any ContraceptionNon-continuous use over 6 months13 Participants
Intervention (MyPath)Continuous Use of Any ContraceptionMissing (lost to follow-up for 6 month survey)11 Participants
Intervention (MyPath)Continuous Use of Any ContraceptionMissing (did not answer question(s) due to pregnancy)0 Participants
Usual CareContinuous Use of Any ContraceptionMissing (did not answer question(s) due to pregnancy)1 Participants
Usual CareContinuous Use of Any ContraceptionContinuous use over 6 months46 Participants
Usual CareContinuous Use of Any ContraceptionMissing (lost to follow-up for 6 month survey)11 Participants
Usual CareContinuous Use of Any ContraceptionNon-continuous use over 6 months6 Participants
Secondary

Continuous Use of Prescription or Procedural Contraception

Self-reported use of a prescription or procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Continuous Use of Prescription or Procedural ContraceptionContinuous Use of Rx/Procedural Contraception45 Participants
Intervention (MyPath)Continuous Use of Prescription or Procedural ContraceptionNon-Continuous Use of Rx/Procedural Contraception30 Participants
Intervention (MyPath)Continuous Use of Prescription or Procedural ContraceptionMissing (lost to follow-up for 6-month survey)11 Participants
Intervention (MyPath)Continuous Use of Prescription or Procedural ContraceptionMissing (did not answer question(s) due to pregnancy)0 Participants
Usual CareContinuous Use of Prescription or Procedural ContraceptionMissing (did not answer question(s) due to pregnancy)1 Participants
Usual CareContinuous Use of Prescription or Procedural ContraceptionContinuous Use of Rx/Procedural Contraception31 Participants
Usual CareContinuous Use of Prescription or Procedural ContraceptionMissing (lost to follow-up for 6-month survey)11 Participants
Usual CareContinuous Use of Prescription or Procedural ContraceptionNon-Continuous Use of Rx/Procedural Contraception21 Participants
Secondary

Continuous Use of Procedural Contraception

Self-reported use of a procedural contraceptive method over the past 6 months without a gap of greater than 4 weeks. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Continuous Use of Procedural ContraceptionContinuous Use of Procedural Contraception27 Participants
Intervention (MyPath)Continuous Use of Procedural ContraceptionNon-continuous Use of Procedural Contraception48 Participants
Intervention (MyPath)Continuous Use of Procedural ContraceptionMissing (lost to follow-up for 6-month survey)11 Participants
Intervention (MyPath)Continuous Use of Procedural ContraceptionMissing (did not answer question(s) due to pregnancy)0 Participants
Usual CareContinuous Use of Procedural ContraceptionMissing (did not answer question(s) due to pregnancy)1 Participants
Usual CareContinuous Use of Procedural ContraceptionContinuous Use of Procedural Contraception19 Participants
Usual CareContinuous Use of Procedural ContraceptionMissing (lost to follow-up for 6-month survey)11 Participants
Usual CareContinuous Use of Procedural ContraceptionNon-continuous Use of Procedural Contraception33 Participants
Secondary

Contraceptive Decision Conflict

Assessed with the Decision Conflict Scale (DCS), a validated measure to assess patients' decisional conflict in medical decision making. The DCS includes 16-items with 5-point Likert scale response options ranging from 0-4. Scores are converted to range from 0 (no decisional conflict) to 100 (highest decisional conflict). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Contraceptive Decision Conflict16.94 ScoreStandard Deviation 17.57
Usual CareContraceptive Decision Conflict20.04 ScoreStandard Deviation 20.67
Comparison: We used a multilevel regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach.p-value: 0.5695% CI: [-9.94, 5.42]Regression, Linear
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome.p-value: 0.0295% CI: [-25.37, -2.06]Regression, Linear
Secondary

Contraceptive Method Satisfaction

Assessed using a single question (How satisfied are you with your current birth control method) with Likert response options from 1 (very dissatisfied) to 5 (very satisfied). This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. While this outcome was measured at 6 months, for participants lost to follow-up at 6 months, we singly imputed these data by pulling forward their 3-month satisfaction, when available.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Contraceptive Method Satisfaction4.28 ScoreStandard Deviation 1.01
Usual CareContraceptive Method Satisfaction4.35 ScoreStandard Deviation 0.95
Secondary

Incidence of Unplanned Pregnancy

Proportion of participants who self-report an unplanned pregnancy, as determined by responses to the 6-item London Measure of Unplanned Pregnancy. The London Measure includes items measuring attitude towards an experienced pregnancy and behaviors before pregnancy to determine the intendedness of pregnancy. The score range of the London Measure is 0-12, with a score of \<10 indicating unplanned pregnancy and a score of 10 or higher indicating planned pregnancy. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Incidence of Unplanned PregnancyUnplanned pregnancy0 Participants
Intervention (MyPath)Incidence of Unplanned PregnancyNo unplanned pregnancy64 Participants
Intervention (MyPath)Incidence of Unplanned PregnancyMissing (lost to follow-up 6 month survey)22 Participants
Usual CareIncidence of Unplanned PregnancyUnplanned pregnancy1 Participants
Usual CareIncidence of Unplanned PregnancyNo unplanned pregnancy42 Participants
Usual CareIncidence of Unplanned PregnancyMissing (lost to follow-up 6 month survey)21 Participants
Secondary

Occurrence of Reproductive Needs Discussion

Self-report of whether a discussion of pregnancy goals, prepregnancy health, or contraception occurred during the scheduled primary care visit, regardless of occurrence of SDM.

Time frame: Within one month post-visit

Population: Enrolled Veterans were excluded from the analytic sample if they were withdrawn from the study prior to any outcomes assessment due to non-attendance at their scheduled primary care visit, pregnancy diagnosed at the scheduled primary care visit, or self-withdrawal prior to outcomes assessment.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Occurrence of Reproductive Needs DiscussionYes (discussion occurred)119 Participants
Intervention (MyPath)Occurrence of Reproductive Needs DiscussionNo (discussion did not occur)49 Participants
Intervention (MyPath)Occurrence of Reproductive Needs DiscussionMissing (lost to follow-up for post-visit survey)21 Participants
Intervention (MyPath)Occurrence of Reproductive Needs DiscussionMissing (declined one or more measure questions)1 Participants
Usual CareOccurrence of Reproductive Needs DiscussionMissing (declined one or more measure questions)0 Participants
Usual CareOccurrence of Reproductive Needs DiscussionYes (discussion occurred)93 Participants
Usual CareOccurrence of Reproductive Needs DiscussionMissing (lost to follow-up for post-visit survey)17 Participants
Usual CareOccurrence of Reproductive Needs DiscussionNo (discussion did not occur)49 Participants
Comparison: We used a multilevel logistic regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach. Analyses accounted for missing data in outcome and baseline adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE).p-value: 0.2695% CI: [0.79, 2.38]Regression, Logistic
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome. Our model accounted for missing data in outcome and baseline adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE) in R.p-value: 0.01995% CI: [1.23, 9.76]Regression, Logistic
Secondary

Perceived Self-efficacy in Communicating With Providers

Assessed with a modified version of the validated 5-item Perceived Efficacy in Patient-Provider Interactions (PEPPI) scale, which uses five Likert scale questions ranging from 1 to 5 (score 5-25, with higher scores indicating higher levels of perceived efficacy).

Time frame: Within one month post-visit

Population: Enrolled Veterans were excluded from the analytic sample if they were withdrawn from the study prior to any outcomes assessment due to non-attendance at their scheduled primary care visit, pregnancy diagnosed at the scheduled primary care visit, or self-withdrawal prior to outcomes assessment.

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Perceived Self-efficacy in Communicating With Providers19.8 ScoreStandard Deviation 4.8
Usual CarePerceived Self-efficacy in Communicating With Providers20.6 ScoreStandard Deviation 4.4
Comparison: We used a multilevel logistic regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach. Analyses accounted for missing data in outcome and baseline adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE).p-value: 0.2795% CI: [-1.71, 0.48]Regression, Linear
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome. Our model accounted for missing data in outcome and baseline adjustment variables through multiple imputation (MI) using Multiple Imputation by Chained Equations (MICE) in R.p-value: 0.4295% CI: [-2.91, 1.22]Regression, Linear
Secondary

Reproductive Health Knowledge

Participant responses to 14 items assessing knowledge of fertility, prepregnancy health, and contraception. The measure is self-developed and derived from previously published assessments of fertility and contraceptive knowledge. Responses will be coded as correct vs. incorrect, with don't know coded as incorrect (score 0-14, with higher scores indicating more accurate knowledge).

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Reproductive Health Knowledge7.94 Number correctStandard Deviation 2.64
Usual CareReproductive Health Knowledge7.89 Number correctStandard Deviation 2.36
Comparison: We used a multilevel logistic regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach.p-value: 0.4595% CI: [-0.56, 1.26]Regression, Linear
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome.p-value: 0.0995% CI: [-0.15, 2.02]Regression, Linear
Secondary

Use of Prescription or Procedural Contraceptive Method

Self-reported use of a prescription or procedural method at follow-up. Prescription or procedural methods are defined as any of the following: birth control pills, patch, ring, injection, implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Use of Prescription or Procedural Contraceptive MethodPrescription or procedural method41 Participants
Intervention (MyPath)Use of Prescription or Procedural Contraceptive MethodNon-prescription or no method23 Participants
Intervention (MyPath)Use of Prescription or Procedural Contraceptive MethodMissing (lost to follow-up 6-month survey)22 Participants
Intervention (MyPath)Use of Prescription or Procedural Contraceptive MethodMissing (did not answer question(s) due to pregnancy)0 Participants
Usual CareUse of Prescription or Procedural Contraceptive MethodMissing (did not answer question(s) due to pregnancy)1 Participants
Usual CareUse of Prescription or Procedural Contraceptive MethodPrescription or procedural method28 Participants
Usual CareUse of Prescription or Procedural Contraceptive MethodMissing (lost to follow-up 6-month survey)21 Participants
Usual CareUse of Prescription or Procedural Contraceptive MethodNon-prescription or no method14 Participants
Secondary

Use of Procedural Contraceptive Method

Self-reported use of a procedural method at follow-up. Procedural methods are defined as any of the following: implants, IUDs, and male and female sterilization. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Use of Procedural Contraceptive MethodProcedural method22 Participants
Intervention (MyPath)Use of Procedural Contraceptive MethodNon-procedural or no method42 Participants
Intervention (MyPath)Use of Procedural Contraceptive MethodMissing (lost to follow-up 6-month survey)22 Participants
Intervention (MyPath)Use of Procedural Contraceptive MethodMissing (did not answer question(s) due to pregnancy)0 Participants
Usual CareUse of Procedural Contraceptive MethodMissing (did not answer question(s) due to pregnancy)1 Participants
Usual CareUse of Procedural Contraceptive MethodProcedural method17 Participants
Usual CareUse of Procedural Contraceptive MethodMissing (lost to follow-up 6-month survey)21 Participants
Usual CareUse of Procedural Contraceptive MethodNon-procedural or no method25 Participants
Other Pre-specified

Contraceptive Knowledge

Participant responses to 8 items assessing knowledge of contraception. The measure derived from previously published assessments of contraceptive knowledge. Responses will be coded as correct vs. incorrect, with don't know coded as incorrect (score 0-8, with higher scores indicating more accurate knowledge).

Time frame: Within one month post-visit

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of current pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureValue (MEAN)Dispersion
Intervention (MyPath)Contraceptive Knowledge4.42 ScoreStandard Deviation 1.72
Usual CareContraceptive Knowledge4.15 ScoreStandard Deviation 1.54
Comparison: We used a multilevel logistic regression model to test whether the outcome was significantly different in the intervention versus control arm, using an Intent to Treat approach.p-value: 0.2195% CI: [-0.22, 0.99]Regression, Linear
Comparison: Per the study protocol, to account for noncompliance, we estimated the complier average causal effect to estimate the causal effect of using the MyPath tool on the outcome.p-value: 0.0495% CI: [0.04, 1.75]Regression, Linear
Other Pre-specified

Goals-concordant Contraceptive Use

Self-reported contraception use among participants at 6 months that is consistent with their orientation towards pregnancy at 6-months (desires pregnancy now, not trying but OK with it, desires pregnancy later but not now, never desires pregnancy, not sure), regardless of their intention at baseline. This measure will be obtained in a pre-defined subset of participants at risk of unintended pregnancy. For Veterans who desire pregnancy now, goals-concordant contraceptive use is defined as not using contraception. For Veterans who desire pregnancy later, never, or are unsure, goals-concordant contraceptive use is defined as using contraception. For Veterans who are not trying to get pregnant but would be OK with it, goals-concordant contraceptive use is defined as either using or not using contraception.

Time frame: 6 months

Population: This outcome was measured within a prespecified analytic subgroup (n=150) defined at study enrollment (pre-intervention) as potentially at risk of unintended pregnancies, defined using baseline measures of pregnancy desires (does not desire pregnancy now or within the next year), pregnancy capability (does not report a prior tubal sterilization) and sexual activity (reports sex with a male partner in the past 12 months).

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention (MyPath)Goals-concordant Contraceptive UseMissing (lost to follow-up at 6-months)22 Participants
Intervention (MyPath)Goals-concordant Contraceptive UseYes (goals-concordant contraceptive use)50 Participants
Intervention (MyPath)Goals-concordant Contraceptive UseMissing (not asked question(s) due to pregnancy)0 Participants
Intervention (MyPath)Goals-concordant Contraceptive UseNo (not goals-concordant contraceptive use)14 Participants
Usual CareGoals-concordant Contraceptive UseMissing (not asked question(s) due to pregnancy)1 Participants
Usual CareGoals-concordant Contraceptive UseYes (goals-concordant contraceptive use)38 Participants
Usual CareGoals-concordant Contraceptive UseMissing (lost to follow-up at 6-months)21 Participants
Usual CareGoals-concordant Contraceptive UseNo (not goals-concordant contraceptive use)4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026